CancerDetect® now features a new serial report. The results from several CancerDetect® analyses are consolidated into a single report, providing oncologists with a clearer and more streamlined way to assess the findings.
For many liquid biopsy-based somatic analyses, it is helpful to look at changes in the results over time and interpret them in the clinical context. With the new monitoring report layout, the data from serial CancerDetect® analyses are summarized in one report and can be interpreted at a glance. The results of each additional sample are integrated into existing reports. An updated progression graph and corresponding tables clearly show a trend of the monitored changes based on the variant frequency. Conclusions can be drawn about the course of the disease, and therapy success and the occurrence of resistance mutations can be recognized in time.
The system has a flexible structure and looks at the frequency change of each somatic variant separately. Therefore, the integration of newly occurring alterations in the monitoring report is always possible. In addition to CancerDetect®-based analyses, data from other analysis types, such as CancerPrecision® from liquid biopsy samples, can also be included in the monitoring findings.